Subventions
et Bourses (de juillet 2005 à juin 2006)
Subventions:
1 452 831$
Bourses:
87 000$
Projets
Subventionnés en 2005
|
Membres
|
Organisme
subventionnaire
|
Projets
|
|
Grant
Andrew
|
Santé
Canada
|
Health
Information Standards Portal
|
|
Grant
Andrew
|
Bayer
Canada
|
Evaluation
program of ADVIA Platforms, Bayer
|
|
Michaud
Sophie
|
FRSQ
|
Recherche évaluative et épidémiologique en prévention des infections: approche
clinique et projet moléculaire (Bourse de chercheur clinicien junior 2)
|
|
Michaud
Sophie
|
FRSQ
|
Epidémiologie
clinique et moleculaire et caractérisation des facteurs de virulence
du Clostridium difficile dans le contexte d’une éclosion récente au Québec
|
|
Michaud
Sophie
|
CRSNG-IRSC
|
A GIS-based
human campylobacteriosis monitoring system: evaluation of the
infectious risk related to water quality
|
|
Michaud
Sophie
|
Canadian
Water Network
|
Examining
the relationship between community health data and pathogen
occurrence in two geographically distinct watersheds
|
|
Patenaude
Johane
|
FRSQ
|
L’évaluation éthique de la recherche biomédicale au Canada : étude évaluative et
prospective pour une gouvernance au service de la démocratie délibérative
|
|
Patenaude
Johane
|
IRSC
|
L’évaluation éthique de la recherche biomédicale au Canada : étude évaluative et
prospective pour une gouvernance au service de la démocratie délibérative
|
|
Pilon
Danielle
|
Régie
Régionale de la
Santé et des Services
Sociaux de l’Estrie
|
Vaccin
anti-pneumoccoccique et risque d’infarctus du myocarde
|
|
Pilon
Danielle
|
IRSC
|
A population-based
analysis of the effect of lipid lowering drug non-compliance on
the health care system
|
|
Pilon
Danielle
|
FRSQ
|
Médicaments
et risque cardiovasculaire (Bourse de chercheur clinicien junior 2)
|
|
Pilon
Danielle
|
Sanofi-synthelabo
Canada Inc.
|
Enquête
observationnelle prospective internationale chez les patients à risque
d’événements arthérothrombotiques
|
|
Denise
St-Cyr
Tribble
|
Fonds
québécois de la
recherche sur la société
et la culture
|
Le transfert
des connaissances entre praticiens gestionnaires et chercheurs
comme source d’Innovation en CLSC
|
|
St-Cyr
Tribble
Denise
|
IRSC
|
Application
des connaissances liées à l,acide folique dans la rpévention des
anomalies congénitales : évaluation de l’implantation d’un programme et des
effets sur les pratqieus professionnelles
|
|
St-Cyr
Tribble
Denise
|
Minstère
de la santé et
des services sociaux
(Québec)
|
Le transfert
des connaissances entre praticiens, gestionnaires et chercheurs
comme source d’innovation en CLSC
|
|
Talbot
Lise
|
FRSQ
|
Évaluation
du processus d’implantation de l’approche Collaborative Care (CC) et
de ses impacts préliminaires sur la distribution de soins et de services en
réadaptation et les coûts chez une clientèle ayant subi un traumatisme crânio-
cérébral (TCC) modéré à sévère
|
|
Valiquette
Louis
|
Santé
Canada
|
Création
d’une échelle de prédiction clinique pour identifier les patients avec
colite à Clostridium Difficile CCD compliquée au moment du diagnostic
|
|
Valiquette
Louis
|
IRSC
|
Derivation
of clinical prediction rules to identify patients with complicated
outcomes after the diagnosis of clostridium difficile associated diarrhea
|
|
Valiquette
Louis
|
Conseil
du médicament
|
Amélioration
de l’utilisation des antibiotiques en milieu hospitalier via le
développement et l'intégration d’un système expert
|
|
Vanasse
Alain
|
FRSQ
|
Ruralité
et maladies chroniques adultes : un programme de recherche en
géomatique de la santé
|
|
Vanasse
Alain
|
GEOIDE/RCE
|
SIST–Chronic
Diseases and Primary Care
|
|
Vanasse
Alain
|
Merck
Frosst Canada Inc
|
SIST-Chronic
diseases and primary care
|
|
Vanasse
Alain
|
FRSQ
|
Cardiologie
préventive et soins de premières lignes (bourse de chercheur
clinicien junior 1)
|
|
Vanasse
Alain
|
FRSQ
|
Une approche
géomatique pour l'étude des maladies chroniques au Québec
(bourse de chercheur clinicien junior 2)
|
Publications
Année
2005: 29 publications
Boire
G, Cossette P, de Brum-Fernandes AJ, Liang P, Niyonsenga T, Zhou ZJ, Carrier
N, Daniel C,
Menard HA. Anti-Sa antibodies and antibodies against cyclic citrullinated peptide are not equivalent
as predictors of severe outcomes in patients with recent-onset polyarthritis., Arthritis Res Ther.
2005;7(3):R592-603.
De Medicis
E, Tetrault JP, Martin R, Robichaud R, Laroche L. A prospective comparative study of
two indirect methods for confirming the localization of an epidural catheter for postoperative
analgesia, Anesth Analg. 2005 Dec;101(6):1830-3.
De
Wals P, Deceuninck G, De Serres G, Boivin JF, Duval B, Remis R, Masse R. Effectiveness of
serogroup C meningococcal polysaccharide vaccine: results from a case- control study in quebec.
Clin Infect Dis.; 40 (8): 1116-22, 2005.
Duval
B, Gilca V, Boulianne N, De Wals P, Masse R, Trudeau G, De Serres G. Comparative long
term immunogenicity of two recombinant hepatitis B vaccines and the effect of a booster dose
given after five years in a low endemicity country. Pediatr Infect Dis J. 24(3):213-8, 2005.
Fortin
M, Bravo G, Hudon C, Vanasse A, Lapointe L. Prevalence of multimorbidity in family
practice, Annals of Family Medicine; 3: 223-8, 2005.
Fortin
M, Lapointe L, Hudon C, Vanasse A. Multimorbidity is common to family practice. Is it
commonly researched? Canadian Family Physician; 51: 244-245, 2005.
Gheorghiu
I, Moshyk A, Lepage R, Ahnadi CE, Grant AM. When is bioavailable testosterone a
redundant test in the diagnosis of hypogonadism in men?. Clinical Biochemistry, 38(9):813-8, 2005.
Gibreel
A, Kos V N, Keelan M, Trieber C A, Lévesque S, Michaud S, Taylor D E. Macrolide
resistance in Campylobacter jejuni and Campylobacter coli: molecular mechanism and stability
of
the resistance phenotype. Antimicrobial Agents and Chemotherapy; 49, 2753-2759, 2005.
Grant
A, Moshyk A, Diab H, Caron P, de Lorenzi F, Bisson G, Menard L, Lefebvre R, Desautels
M.
Integrating feedback from a clinical datawarehouse into practice organisation. International Journal
of Health Informatics, 2005.
Hudon
C, Fortin M, Vanasse A. Cumulative Illness Rating Scale was a reliable and valid index in
a
family practice context, Journal of Clinical Epidemiology; 58(6):603-8, 2005.
Lefebvre
B, Diarra MS, Giguere K, Roy G, Michaud S, Malouin F.Antibiotic resistance and
hypermutability of Escherichia coli O157 from feedlot cattle treated with growth- promoting agents.
Journal of Food Protection. 68(11):2411-9, 2005.
Loo V,
Poirier L, Miller M A, Oughton M, Libman M D, Michaud S, Bourgault A-M, Nguyen T,
Frenette C, Kelly M, Vibien A, Brassard P, Fenn S, Dewar K, Hudson T J, Horn R, René P, Monczak
Y, Dascal A. A Predominantly Clonal Multi- Institutional Outbreak of Clostridium difficile- Associated
Diarrhea Associated with High Morbidity and Mortality. N Engl J Med. 353(23):2442- 9, 2005.
Michaud
S, Ménard S, Arbeit R D. Role of real-time molecular typing in the surveillance of
campylobacter enteritis and comparison between PFGE profiles from chicken and human isolates.
Journal of Clinical Microbiology; 43:1105-1111, 2005.
Paquet
M, Bolduc N, Xhignesse M, Vanasse A, Re- engineering cardiac rehabilitation
programmes: considering the patient’s point of view, Journal of Advanced Nursing; 51(6):
567-
576, 2005.
Pepin
J, Labbe AC, Khonde N, Deslandes S, Alary M, Dzokoto A, Asamoah-Adu C, Meda H, Frost
E. Mycoplasma genitalium: an organism commonly associated with cervicitis among west African
sex workers. Sex Transm Infect. 81(1):67-72, 2005.
Pepin
J, Mpia B. Secular changes in the frequency of relapses after melarsoprol therapy of T. b.
gambiense trypanosomiasis in the Nioki focus, Democratic Republic of Congo, 1982-2001. Emerg
Infect Dis; 11: 921-927, 2005.
Pepin
J, Valiquette L and Cossette B. Mortality attributable to nosocomial Clostridium difficile-
associated disease during an epidemic caused by a hypervirulent strain in Quebec.
Cmaj.173(9):1037-42, 2005.
Pepin
J, Alary ME, Valiquette L, Raiche E, Ruel J, Fulop K, Godin D, Bourassa C. Increasing risk
of relapse after treatment of Clostridium difficile colitis in Québec. Clin Infect Dis.
40(11):1591- 7,
2005.
Pepin J, Mpia
B. Trypanosomiasis relapse after melarsoprol therapy, Democratic Republic of congo, 1982-2001 Emerg
Infect DIS. 11(6): 921-7, 2005.
Pepin
J. From the Old World to the New World: an ecologic study of population susceptibility to HIV
infection. Trop Med Int Health. 2005 Jul;10(7):627-39. Erratum in: Trop Med Int Health ;10(9):944,
2005.
Pepin
J, Saheb N, Coulombe MA, Alary ME, Corriveau MP, Authier S, Leblanc M, Rivard G, Bettez
M, Primeau V, Nguyen M, Jacob CE, Lanthier L. Emergence of fluoroquinolones as the predominant
risk factor for Clostridium difficile associated diarrhea: a cohort study during an epidemic
in
Quebec. Clinf Infect Dis; 41: 1254- 1260, 2005.
Talbot
LR, Vincent, C. Technologies au service du soin. Gérontologie et société,
no 113, p. 51-
61, 2005.
Talbot
LR.L’humanité des soins : défi professionnel et richesse sociale. Perspectives
infirmières.
Vol.2, no3, p.16, 2005.
Talbot
LR. The challenge of taking care. Perspectives infirmières. 2(3):16, 2005.
Vanasse
A, Demers M, Hemiari A, Courteau J. Obesity in Canada: Where and How many?
International Journal of Obesity, advance online publication, doi:10.1038/sj.ijo.0803168, 2005.
Vanasse
A, Dagenais P, Niyosenga T, Courteau J, Gregoire JP, Hemiari A. Bone densitometry
and osteoporosis treatment after a fragility fracture in older adults : regional variation and
determinants of use in Quebec, BMC Musculoskeletical Disorders; 6: 33, 2005.
Vanasse
A, Niyosenga T, Courteau J, Hemiari A, Loslier J, Gregoire JP, Benie GB. Spatial
variation in the management and outcomes of acute coronary syndrome, BMC Cardiovascular
Disorders; 5: 21, 2005.
Warny
M, Pepin J, Fang A, Killgore G, Thompson A, Brazier J, Frost E, Mc Donald LC. Toxin
production by an emerging strain of Clostridium difficile associated with outbreaks of severe
disease in North America and Europe. Lancet 366(9491):1079-84, 2005.
Wians
FH Jr, Wilson BA, Grant A, Bailey J, Gheorghiu I, Conarpe C, Mindicino H, Thakur K, Belenky
A, Despres N, Bluestein B. Evaluation of the analytical performance characteristics of the Bayer
ACS:180 B- type natriuretic peptide (BNP) assay. Clin Chim Acta. 353(1-2):147- 55, 2005.
1. La Recherche évaluative
